Korean J Gastroenterol.  2023 Aug;82(2):47-55. 10.4166/kjg.2023.091.

Calcium, Vitamin D, and Colorectal Cancer

• Wi YJ
• Na SY

• KMID: 2545328
• DOI: http://doi.org/10.4166/kjg.2023.091

Abstract

Colorectal cancer has a high incidence and mortality worldwide, with Westernized lifestyles and diet being significant contributing factors. Vitamin D and calcium have been known to reduce the incidence of colorectal cancer by affecting cell differentiation, proliferation, and apoptosis. Despite observational studies which have suggested that a higher serum vitamin D level can lower the risk of colorectal cancer and improve survival rates, no large-scale randomized controlled trials to establish these benefits have been conducted to date. Calcium intake has also been found to have a beneficial role in reducing the incidence and improving survival rates of colorectal cancer in several observational studies. Moreover, intervention studies have proved its effect in preventing colorectal adenomas. However, there are few intervention studies that have identified the relationship of vitamin D and calcium with colon cancer. To elucidate the impact of vitamin D and calcium supplementation on colorectal cancer, well-designed and large-scale randomized controlled trials are necessary in the future.

Keyword

Vitamin D; Calcium; Colorectal neoplasms

Figure

• 

  Fig. 1 Metabolic pathways of vitamin D. Vitamin D3 (cholecalciferol), vitamin D2 (ergocalciferol), calcidiol, and calcitriol.

• 

  Fig. 2 Mechanisms of intestinal calcium absorption.

Reference

1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021; 71:209–249. DOI: 10.3322/caac.21660. PMID: 33538338.

2. Murphy N, Moreno V, Hughes DJ, et al. 2019; Lifestyle and dietary environmental factors in colorectal cancer susceptibility. Mol Aspects Med. 69:2–9. DOI: 10.1016/j.mam.2019.06.005. PMID: 31233770.

3. Keum N, Giovannucci E. 2019; Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 16:713–732. DOI: 10.1038/s41575-019-0189-8. PMID: 31455888.

4. Rubio CA. 2021; Two intertwined compartments coexisting in sporadic conventional colon adenomas. Intest Res. 19:12–20. DOI: 10.5217/ir.2019.00133. PMID: 32079382. PMCID: PMC7873396.

5. Gweon TG, Yoon KT, Kim CH, Kim JJ. 2021; Postgastrectomy gastric cancer patients are at high risk for colorectal neoplasia: a case control study. Intest Res. 19:239–246. DOI: 10.5217/ir.2020.00009. PMID: 33181006. PMCID: PMC8100371.

6. Kim SH, Lim YJ. 2022; The role of microbiome in colorectal carcinogenesis and its clinical potential as a target for cancer treatment. Intest Res. 20:31–42. DOI: 10.5217/ir.2021.00034. PMID: 34015206. PMCID: PMC8831768.

7. Park CH, Yang DH, Kim JW, et al. 2021; Clinical practice guideline for endoscopic resection of early gastrointestinal cancer. Intest Res. 19:127–157. DOI: 10.5217/ir.2020.00020. PMID: 33045799. PMCID: PMC8100377.

8. Brenner H, Chen C. 2018; The colorectal cancer epidemic: challenges and opportunities for primary, secondary and tertiary prevention. Br J Cancer. 119:785–792. DOI: 10.1038/s41416-018-0264-x. PMID: 30287914. PMCID: PMC6189126.

9. Williams JD, Aggarwal A, Swami S, et al. 2016; Tumor autonomous effects of vitamin D deficiency promote breast cancer metastasis. Endocrinology. 157:1341–1347. DOI: 10.1210/en.2015-2036. PMID: 26934299. PMCID: PMC4816742.

10. Fleet JC, Burcham GN, Calvert RD, Elzey BD, Ratliff TL. 2020; 1α, 25 Dihydroxyvitamin D (1,25(OH)2D) inhibits the T cell suppressive function of myeloid derived suppressor cells (MDSC). J Steroid Biochem Mol Biol. 198:105557. DOI: 10.1016/j.jsbmb.2019.105557. PMID: 31783150. PMCID: PMC8041088.

11. Milner JA, McDonald SS, Anderson DE, Greenwald P. 2001; Molecular targets for nutrients involved with cancer prevention. Nutr Cancer. 41:1–16. DOI: 10.1207/S15327914NC41-1&2_1.

12. Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. 2016; Vitamin D: Metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev. 96:365–408. DOI: 10.1152/physrev.00014.2015. PMID: 26681795. PMCID: PMC4839493.

13. Lamprecht SA, Lipkin M. 2003; Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nat Rev Cancer. 3:601–614. DOI: 10.1038/nrc1144. PMID: 12894248.

14. Kósa JP, Horváth P, Wölfling J, et al. 2013; CYP24A1 inhibition facilitates the anti-tumor effect of vitamin D3 on colorectal cancer cells. World J Gastroenterol. 19:2621–2628. DOI: 10.3748/wjg.v19.i17.2621. PMID: 23674869. PMCID: PMC3645380.

15. Ferrer-Mayorga G, Larriba MJ, Crespo P, Muñoz A. 2019; Mechanisms of action of vitamin D in colon cancer. J Steroid Biochem Mol Biol. 185:1–6. DOI: 10.1016/j.jsbmb.2018.07.002. PMID: 29981368.

16. Belleli A, Shany S, Levy J, Guberman R, Lamprecht SA. 1992; A protective role of 1,25-dihydroxyvitamin D3 in chemically induced rat colon carcinogenesis. Carcinogenesis. 13:2293–2298. DOI: 10.1093/carcin/13.12.2293. PMID: 1335376.

17. Cancer Genome Atlas Network. 2012; Comprehensive molecular characterization of human colon and rectal cancer. Nature. 487:330–337. DOI: 10.1038/nature11252. PMID: 22810696. PMCID: PMC3401966.

18. Chen A, Davis BH, Sitrin MD, Brasitus TA, Bissonnette M. 2002; Transforming growth factor-beta 1 signaling contributes to Caco-2 cell growth inhibition induced by 1,25(OH)(2)D(3). Am J Physiol Gastrointest Liver Physiol. 283:G864–G874. DOI: 10.1152/ajpgi.00524.2001. PMID: 12223346.

19. Bronner F. 2003; Mechanisms of intestinal calcium absorption. J Cell Biochem. 88:387–393. DOI: 10.1002/jcb.10330. PMID: 12520541.

20. Brown EM. 1999; Physiology and pathophysiology of the extracellular calcium-sensing receptor. Am J Med. 106:238–253. DOI: 10.1016/S0002-9343(98)00418-5. PMID: 10230755.

21. Lamprecht SA, Lipkin M. 2001; Cellular mechanisms of calcium and vitamin D in the inhibition of colorectal carcinogenesis. Ann N Y Acad Sci. 952:73–87. DOI: 10.1111/j.1749-6632.2001.tb02729.x. PMID: 11795445.

22. Newmark HL, Wargovich MJ, Bruce WR. 1984; Colon cancer and dietary fat, phosphate, and calcium: a hypothesis. J Natl Cancer Inst. 72:1323–1325.

23. Blobe GC, Obeid LM, Hannun YA. 1994; Regulation of protein kinase C and role in cancer biology. Cancer Metastasis Rev. 13:411–431. DOI: 10.1007/BF00666107. PMID: 7712599.

24. Frey MR, Clark JA, Leontieva O, Uronis JM, Black AR, Black JD. 2000; Protein kinase C signaling mediates a program of cell cycle withdrawal in the intestinal epithelium. J Cell Biol. 151:763–778. DOI: 10.1083/jcb.151.4.763. PMID: 11076962. PMCID: PMC2169440.

25. Chakrabarty S, Radjendirane V, Appelman H, Varani J. 2003; Extracellular calcium and calcium sensing receptor function in human colon carcinomas: promotion of E-cadherin expression and suppression of beta-catenin/TCF activation. Cancer Res. 63:67–71.

26. Kállay E, Kifor O, Chattopadhyay N, et al. 1997; Calcium-dependent c-myc proto-oncogene expression and proliferation of Caco-2 cells: a role for a luminal extracellular calcium-sensing receptor. Biochem Biophys Res Commun. 232:80–83. DOI: 10.1006/bbrc.1997.6225. PMID: 9125156.

27. Garland CF, Garland FC. 1980; Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol. 9:227–231. DOI: 10.1093/ije/9.3.227. PMID: 7440046.

28. Ng K, Sargent DJ, Goldberg RM, et al. 2011; Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741. J Clin Oncol. 29:1599–1606. DOI: 10.1200/JCO.2010.31.7255. PMID: 21422438. PMCID: PMC3082978.

29. Yuan C, Sato K, Hollis BW, et al. 2019; Plasma 25-hydroxyvitamin D levels and survival in patients with advanced or metastatic colorectal cancer: Findings from CALGB/SWOG 80405 (Alliance). Clin Cancer Res. 25:7497–7505. DOI: 10.1158/1078-0432.CCR-19-0877. PMID: 31548349. PMCID: PMC6911644.

30. Chandler PD, Buring JE, Manson JE, et al. 2015; Circulating vitamin D levels and risk of colorectal cancer in women. Cancer Prev Res (Phila). 8:675–682. DOI: 10.1158/1940-6207.CAPR-14-0470. PMID: 25813525. PMCID: PMC4526335.

31. McCullough ML, Zoltick ES, Weinstein SJ, et al. 2019; Circulating vitamin D and colorectal cancer risk: An international pooling project of 17 cohorts. J Natl Cancer Inst. 111:158–169. DOI: 10.1093/jnci/djy087. PMID: 29912394. PMCID: PMC6376911.

32. Huang D, Lei S, Wu Y, et al. 2020; Additively protective effects of vitamin D and calcium against colorectal adenoma incidence, malignant transformation and progression: A systematic review and meta-analysis. Clin Nutr. 39:2525–2538. DOI: 10.1016/j.clnu.2019.11.012. PMID: 31784301.

33. Zhang L, Zou H, Zhao Y, et al. 2019; Association between blood circulating vitamin D and colorectal cancer risk in Asian countries: a systematic review and dose-response meta-analysis. BMJ Open. 9:e030513. DOI: 10.1136/bmjopen-2019-030513. PMID: 31874870. PMCID: PMC7008426.

34. Kim H, Lipsyc-Sharf M, Zong X, et al. 2021; Total vitamin D intake and risks of early-onset colorectal cancer and precursors. Gastroenterology. 161:1208–1217.e9. DOI: 10.1053/j.gastro.2021.07.002. PMID: 34245763. PMCID: PMC8463427.

35. Maalmi H, Ordóñez-Mena JM, Schöttker B, Brenner H. 2014; Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies. Eur J Cancer. 50:1510–1521. DOI: 10.1016/j.ejca.2014.02.006. PMID: 24582912.

36. Wu G, Xue M, Zhao Y, et al. 2020; Low circulating 25-hydroxyvitamin D level is associated with increased colorectal cancer mortality: a systematic review and dose-response meta-analysis. Biosci Rep. 40:BSR20201008. DOI: 10.1042/BSR20201008. PMID: 32686830. PMCID: PMC7391129.

37. Trivedi DP, Doll R, Khaw KT. 2003; Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ. 326:469. DOI: 10.1136/bmj.326.7387.469. PMID: 12609940. PMCID: PMC150177.

38. Wactawski-Wende J, Kotchen JM, Anderson GL, et al. 2006; Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 354:684–696. DOI: 10.1056/NEJMoa055222. PMID: 16481636.

39. Bolland MJ, Grey A, Gamble GD, Reid IR. 2011; Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set. Am J Clin Nutr. 94:1144–1149. DOI: 10.3945/ajcn.111.015032. PMID: 21880848. PMCID: PMC3173029.

40. Manson JE, Cook NR, Lee IM, et al. 2019; Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 380:33–44. DOI: 10.1056/NEJMoa1809944. PMID: 30415629. PMCID: PMC6425757.

41. Lappe J, Watson P, Travers-Gustafson D, et al. 2017; Effect of vitamin D and calcium supplementation on cancer incidence in older women: A randomized clinical trial. JAMA. 317:1234–1243. DOI: 10.1001/jama.2017.2115. PMID: 28350929.

42. Virtanen JK, Nurmi T, Aro A, et al. 2022; Vitamin D supplementation and prevention of cardiovascular disease and cancer in the Finnish Vitamin D Trial: a randomized controlled trial. Am J Clin Nutr. 115:1300–1310. DOI: 10.1093/ajcn/nqab419. PMID: 34982819. PMCID: PMC9071497.

43. Baron JA, Barry EL, Mott LA, et al. 2015; A Trial of calcium and vitamin D for the prevention of colorectal adenomas. N Engl J Med. 373:1519–1530. DOI: 10.1056/NEJMoa1500409. PMID: 26465985. PMCID: PMC4643064.

44. Ng K, Nimeiri HS, McCleary NJ, et al. 2019; Effect of high-dose vs standard-dose vitamin D3 supplementation on progression-free survival among patients with advanced or metastatic colorectal cancer: The SUNSHINE randomized clinical trial. JAMA. 321:1370–1379. DOI: 10.1001/jama.2019.2402. PMID: 30964527. PMCID: PMC6459117.

45. Urashima M, Ohdaira H, Akutsu T, et al. 2019; Effect of vitamin D supplementation on relapse-free survival among patients with digestive tract cancers: The AMATERASU randomized clinical trial. JAMA. 321:1361–1369. DOI: 10.1001/jama.2019.2210. PMID: 30964526. PMCID: PMC6459116.

46. Vaughan-Shaw PG, Buijs LF, Blackmur JP, et al. 2020; The effect of vitamin D supplementation on survival in patients with colorectal cancer: systematic review and meta-analysis of randomised controlled trials. Br J Cancer. 123:1705–1712. DOI: 10.1038/s41416-020-01060-8. PMID: 32929196. PMCID: PMC7686489.

47. Garland C, Shekelle RB, Barrett-Connor E, Criqui MH, Rossof AH, Paul O. 1985; Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet. 1:307–309. DOI: 10.1016/S0140-6736(85)91082-7. PMID: 2857364.

48. Wu K, Willett WC, Fuchs CS, Colditz GA, Giovannucci EL. 2002; Calcium intake and risk of colon cancer in women and men. J Natl Cancer Inst. 94:437–446. DOI: 10.1093/jnci/94.6.437. PMID: 11904316.

49. Lopez-Caleya JF, Ortega-Valín L, Fernández-Villa T, Delgado-Rodríguez M, Martín-Sánchez V, Molina AJ. 2022; The role of calcium and vitamin D dietary intake on risk of colorectal cancer: systematic review and meta-analysis of case-control studies. Cancer Causes Control. 33:167–182. DOI: 10.1007/s10552-021-01512-3. PMID: 34708323.

50. Huncharek M, Muscat J, Kupelnick B. 2009; Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a meta-analysis of 26,335 cases from 60 observational studies. Nutr Cancer. 61:47–69. DOI: 10.1080/01635580802395733. PMID: 19116875.

51. Keum N, Aune D, Greenwood DC, Ju W, Giovannucci EL. 2014; Calcium intake and colorectal cancer risk: dose-response meta-analysis of prospective observational studies. Int J Cancer. 135:1940–1948. DOI: 10.1002/ijc.28840. PMID: 24623471.

52. Yang B, McCullough ML, Gapstur SM, et al. 2014; Calcium, vitamin D, dairy products, and mortality among colorectal cancer survivors: the cancer prevention study-II nutrition cohort. J Clin Oncol. 32:2335–2343. DOI: 10.1200/JCO.2014.55.3024. PMID: 24958826.

53. Yang W, Ma Y, Smith-Warner S, et al. 2019; Calcium intake and survival after colorectal cancer diagnosis. Clin Cancer Res. 25:1980–1988. DOI: 10.1158/1078-0432.CCR-18-2965. PMID: 30545821. PMCID: PMC7023298.

54. Cats A, Kleibeuker JH, van der Meer R, et al. 1995; Randomized, double-blinded, placebo-controlled intervention study with supplemental calcium in families with hereditary nonpolyposis colorectal cancer. J Natl Cancer Inst. 87:598–603. DOI: 10.1093/jnci/87.8.598. PMID: 7752258.

55. Bonithon-Kopp C, Kronborg O, Giacosa A, Räth U, Faivre J. 2000; Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. Lancet. 356:1300–1306. DOI: 10.1016/S0140-6736(00)02813-0. PMID: 11073017.

56. Baron JA, Beach M, Mandel JS, et al. 1999; Calcium supplements for the prevention of colorectal adenomas. N Engl J Med. 340:101–107. DOI: 10.1056/NEJM199901143400204. PMID: 9887161.

57. Bonovas S, Fiorino G, Lytras T, Malesci A, Danese S. 2016; Calcium supplementation for the prevention of colorectal adenomas: A systematic review and meta-analysis of randomized controlled trials. World J Gastroenterol. 22:4594–4603. DOI: 10.3748/wjg.v22.i18.4594. PMID: 27182169. PMCID: PMC4858641.

58. Bristow SM, Bolland MJ, MacLennan GS, et al. 2013; Calcium supplements and cancer risk: a meta-analysis of randomised controlled trials. Br J Nutr. 110:1384–1393. DOI: 10.1017/S0007114513001050. PMID: 23601861.